The American Journal of Medicine
Volume 122, Issue 2 , Pages 152-161 , February 2009

The Impact of Revascularization on Mortality in Patients with Nonacute Coronary Artery Disease

  • Allen Jeremias, MD, MSc

      Affiliations

    • Department of Medicine (Cardiovascular Medicine), Stony Brook University Medical Center, Stony Brook, NY
  • ,
  • Sanjay Kaul, MD

      Affiliations

    • Division of Cardiology, Cedars-Sinai Medical Center and David Geffen School of Medicine, University of California, Los Angeles, Calif
  • ,
  • Todd K. Rosengart, MD

      Affiliations

    • Department of Surgery (Cardiothoracic Surgery), Stony Brook University Medical Center, Stony Brook, NY
  • ,
  • Luis Gruberg, MD

      Affiliations

    • Department of Medicine (Cardiovascular Medicine), Stony Brook University Medical Center, Stony Brook, NY
  • ,
  • David L. Brown, MD

      Affiliations

    • Department of Medicine (Cardiovascular Medicine), Stony Brook University Medical Center, Stony Brook, NY
    • Corresponding Author InformationRequests for reprints should be addressed to David L. Brown, MD, Division of Cardiovascular Medicine, State University of New York-Stony Brook School of Medicine, Health Sciences Center T16-080, Stony Brook, NY 11794

References 

  1. Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction—summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol. 2002;40:1366–1374
  2. Davies RF, Goldberg AD, Forman S, et al. Asymptomatic Cardiac Ischemia Pilot (ACIP) study two-year follow-up: outcomes of patients randomized to initial strategies of medical therapy versus revascularization. Circulation. 1997;95:2037–2043
  3. Madsen JK, Grande P, Saunamaki K, et al. Danish multicenter randomized study of invasive versus conservative treatment in patients with inducible ischemia after thrombolysis in acute myocardial infarction (DANAMI) (DANish trial in Acute Myocardial Infarction). Circulation. 1997;96:748–755
  4. Yusuf S, Zucker D, Peduzzi P, et al. Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration. Lancet. 1994;344:563–570
  5. Alderman EL, Bourassa MG, Cohen LS, et al. Ten-year follow-up of survival and myocardial infarction in the randomized Coronary Artery Surgery Study. Circulation. 1990;82:1629–1646
  6. European Coronary Surgery Study Group. Coronary-artery bypass surgery in stable angina pectoris: survival at two years. Lancet. 1979;1:889–893
  7. Myocardial infarction and mortality in the coronary artery surgery study (CASS) randomized trial. N Engl J Med. 1984;310:750–758
  8. Coronary angioplasty versus medical therapy for angina: the second Randomised Intervention Treatment of Angina (RITA-2) trial (RITA-2 trial participants). Lancet. 1997;350:461–468
  9. Trial of invasive versus medical therapy in elderly patients with chronic symptomatic coronary-artery disease (TIME): a randomised trial. Lancet. 2001;358:951–957
  10. Boden WE, O'Rourke RA, Teo KK, et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med. 2007;356:1503–1516
  11. Katritsis DG, Ioannidis JP. Percutaneous coronary intervention versus conservative therapy in nonacute coronary artery disease: a meta-analysis. Circulation. 2005;111:2906;2612
  12. Bakhai A, Hill RA, Dundar Y, et al. Percutaneous transluminal coronary angioplasty with stents versus coronary artery bypass grafting for people with stable angina or acute coronary syndromes. Cochrane Database Syst Rev. 2005;CD004588
  13. Coronary angioplasty versus coronary artery bypass surgery: the Randomized Intervention Treatment of Angina (RITA) trial. Lancet. 1993;341:573–580
  14. Hamm CW, Reimers J, Ischinger T, et al. A randomized study of coronary angioplasty compared with bypass surgery in patients with symptomatic multivessel coronary disease (German Angioplasty Bypass Surgery Investigation (GABI)). N Engl J Med. 1994;331:1037–1043
  15. King SB, Lembo NJ, Weintraub WS, et al. A randomized trial comparing coronary angioplasty with coronary bypass surgery (Emory Angioplasty versus Surgery Trial (EAST)). N Engl J Med. 1994;331:1044–1050
  16. The Bypass Angioplasty Revascularization Investigation (BARI) Investigators. Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. N Engl J Med. 1996;335:217–225
  17. Serruys PW, Unger F, Sousa JE, et al. Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease. N Engl J Med. 2001;344:1117–1124
  18. Bravata DM, Gienger AL, McDonald KM, et al. Systematic review: the comparative effectiveness of percutaneous coronary interventions and coronary artery bypass surgery. Ann Intern Med. 2007;147:703–716
  19. Rosenberg MS. The file-drawer problem revisited: a general weighted method for calculating fail-safe numbers in meta-analysis. Int J Org Evol. 2005;59:464–468
  20. Hueb WA, Bellotti G, de Oliveira SA, et al. The Medicine, Angioplasty or Surgery Study (MASS): a prospective, randomized trial of medical therapy, balloon angioplasty or bypass surgery for single proximal left anterior descending artery stenoses. J Am Coll Cardiol. 1995;26:1600–1605
  21. Hueb W, Lopes NH, Gersh BJ, et al. Five-year follow-up of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease. Circulation. 2007;115:1082–1089
  22. Yousef ZR, Redwood SR, Bucknall CA, et al. Late intervention after anterior myocardial infarction: effects on left ventricular size, function, quality of life, and exercise tolerance: results of the Open Artery Trial (TOAT Study). J Am Coll Cardiol. 2002;40:869–876
  23. Steg PG, Thuaire C, Himbert D, et al. DECOPI (DEsobstruction COronaire en Post-Infarctus): a randomized multi-centre trial of occluded artery angioplasty after acute myocardial infarction. Eur Heart J. 2004;25:2187–2194
  24. Hochman JS, Lamas GA, Buller CE, et al. Coronary intervention for persistent occlusion after myocardial infarction. N Engl J Med. 2006;355:2395–2407
  25. Serruys PW, Ong AT, van Herwerden LA, et al. Five-year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease: the final analysis of the Arterial Revascularization Therapies Study (ARTS) randomized trial. J Am Coll Cardiol. 2005;46:575–581
  26. Gibbons RJ, Abrams J, Chatterjee K, et al. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina—summary article: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on the Management of Patients With Chronic Stable Angina). J Am Coll Cardiol. 2003;41:159–168
  27. Hambrecht R, Walther C, Mobius-Winkler S, et al. Percutaneous coronary angioplasty compared with exercise training in patients with stable coronary artery disease: a randomized trial. Circulation. 2004;109:1371–1378
  28. Mathur VS, Guinn GA. Prospective randomized study of the surgical therapy of stable angina. Cardiovasc Clin. 1977;8:131–144
  29. Kloster FE, Kremkau EL, Ritzmann LW, et al. Coronary bypass for stable angina: a prospective randomized study. N Engl J Med. 1979;300:149–157
  30. Norris RM, Agnew TM, Brandt PW, et al. Coronary surgery after recurrent myocardial infarction: progress of a trial comparing surgical with nonsurgical management for asymptomatic patients with advanced coronary disease. Circulation. 1981;63:785–792
  31. The Veterans Administration Coronary Artery Bypass Surgery Cooperative Study Group. Eleven-year survival in the Veterans Administration randomized trial of coronary bypass surgery for stable angina. N Engl J Med. 1984;311:1333–1339
  32. Parisi AF, Folland ED, Hartigan P. A comparison of angioplasty with medical therapy in the treatment of single-vessel coronary artery disease (Veterans Affairs ACME Investigators). N Engl J Med. 1992;326:10–16
  33. Hartigan PM, Giacomini JC, Folland ED, Parisi AF. Two- to three-year follow-up of patients with single-vessel coronary artery disease randomized to PTCA or medical therapy (results of a VA cooperative study) (Veterans Affairs Cooperative Studies Program ACME Investigators. Angioplasty Compared to Medicine). Am J Cardiol. 1998;82:1445–1450
  34. Ellis SG, Mooney MR, George BS, et al. Randomized trial of late elective angioplasty versus conservative management for patients with residual stenoses after thrombolytic treatment of myocardial infarction (Treatment of Post-Thrombolytic Stenoses (TOPS) Study Group). Circulation. 1992;86:1400–1406
  35. Sievers N, Hamm CW, Herzner A, Kuck KH. Medical therapy versus PTCA: a prospective, randomized trial in patients with asymptomatic coronary single-vessel disease. Circulation. 1993;88:I-297;(abstract)
  36. Folland ED, Hartigan PM, Parisi AF. Percutaneous transluminal coronary angioplasty versus medical therapy for stable angina pectoris: outcomes for patients with double-vessel versus single-vessel coronary artery disease in a Veterans Affairs Cooperative randomized trial (Veterans Affairs ACME Investigators). J Am Coll Cardiol. 1997;29:1505–1511
  37. Dakik HA, Kleiman NS, Farmer JA, et al. Intensive medical therapy versus coronary angioplasty for suppression of myocardial ischemia in survivors of acute myocardial infarction: a prospective, randomized pilot study. Circulation. 1998;98:2017–2023
  38. Horie H, Takahashi M, Minai K, et al. Long-term beneficial effect of late reperfusion for acute anterior myocardial infarction with percutaneous transluminal coronary angioplasty. Circulation. 1998;98:2377–2382
  39. Pitt B, Waters D, Brown WV, et al. Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease (Atorvastatin versus Revascularization Treatment Investigators). N Engl J Med. 1999;341:70–76
  40. Jeger RV, Bonetti PO, Zellweger MJ, et al. Influence of revascularization on long-term outcome in patients>or =75 years of age with diabetes mellitus and angina pectoris. Am J Cardiol. 2005;96:193–198
  41. Bech GJ, De Bruyne B, Pijls NH, et al. Fractional flow reserve to determine the appropriateness of angioplasty in moderate coronary stenosis: a randomized trial. Circulation. 2001;103:2928–2934
  42. Zeymer U, Uebis R, Vogt A, et al. Randomized comparison of percutaneous transluminal coronary angioplasty and medical therapy in stable survivors of acute myocardial infarction with single vessel disease: a study of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausarzte. Circulation. 2003;108:1324–1328
  43. Hueb W, Soares PR, Gersh BJ, et al. The medicine, angioplasty, or surgery study (MASS-II): a randomized, controlled clinical trial of three therapeutic strategies for multivessel coronary artery disease: one-year results. J Am Coll Cardiol. 2004;43:1743–1751
  44. Mahmarian JJ, Dakik HA, Filipchuk NG, et al. An initial strategy of intensive medical therapy is comparable to that of coronary revascularization for suppression of scintigraphic ischemia in high-risk but stable survivors of acute myocardial infarction. J Am Coll Cardiol. 2006;48:2458–2467
  45. Erne P, Schoenenberger AW, Burckhardt D, et al. Effects of percutaneous coronary interventions in silent ischemia after myocardial infarction: the SWISSI II randomized controlled trial. JAMA. 2007;297:1985–1991

 Funding: None.

 Conflict of Interest: None of the authors have any conflicts of interest associated with the work presented in this article.

 Authorship: All authors had access to the data and were involved as follows: Conception (AJ, TKR, LG, DLB); statistical analysis (AJ, SK, DLB); writing of article (AJ, DLB); critical review (AJ, SK, TKR, LG, DLB).

PII: S0002-9343(08)00955-8

doi: 10.1016/j.amjmed.2008.07.027

The American Journal of Medicine
Volume 122, Issue 2 , Pages 152-161 , February 2009